GLP-1 and Fertility: What to Know Before Using Ozempic If You Want to Get Pregnant

[Image: Illustration of ovarian follicles and GLP-1 receptor signaling]

Here's something that surprises most people: your eggs aren't just passive passengers waiting to be fertilized. They have their own hormonal receptors, including receptors for GLP-1 — the hormone these drugs mimic. A 2024 study in the Journal of Clinical Endocrinology & Metabolism found that women with a BMI over 30 who took semaglutide before IVF had better egg maturation rates and higher live birth rates than women who didn't. That's not just because they lost weight. It's because the GLP-1 receptor in the ovary was doing something useful.

The cells around your eggs — called granulosa cells — are responsible for feeding your egg the nutrients and hormones it needs to mature properly. When insulin levels are too high (very common in PCOS and in women with higher BMI), granulosa cells function poorly. GLP-1 drugs fix the insulin problem, which improves the environment your eggs develop in. Lower insulin means lower androgens, which means your follicles respond better to the FSH signal telling them to grow. 🎯

For women with PCOS who aren't ovulating regularly, this matters enormously. Studies show that 50 to 65 percent of women with PCOS who weren't ovulating resume ovulation with GLP-1 treatment. That's a lot of pregnancies that happen naturally — without IVF — simply because the hormone environment improved enough for the cycle to work again.

Weight loss also improves the lining of your uterus (the endometrium). A thicker, more receptive endometrium means a better chance that a fertilized egg will implant successfully. All of this adds up to a meaningful fertility benefit — when the timing is right.

Here's the part you cannot skip. Semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) are classified as contraindicated in pregnancy. That's the strongest safety warning a drug can carry short of an outright ban. The reason is animal studies showing embryotoxic effects at relevant doses — meaning harm to the developing embryo. No large human safety study exists (because no one ethically runs those), so the precautionary principle applies.

Semaglutide has a half-life of about one week, which means it takes roughly five weeks to fully clear your system. The standard guidance from reproductive endocrinologists is a minimum two-month washout period before attempting conception. Some clinics recommend three months to be safe. The math matters: if your IVF retrieval is scheduled for October, you should probably stop your GLP-1 drug in July at the latest — not the week before retrieval. 📅

This also means you need to have a contraception plan while you're on the drug. GLP-1 drugs can restore ovulation in women who were anovulatory — meaning you might start ovulating without knowing it, especially if you have PCOS. Unintended pregnancy while on the drug is a real risk for women in this situation. Use reliable contraception during the treatment period.

Have this conversation with your reproductive endocrinologist or OB before starting any GLP-1 drug. They can help you build a timeline that includes a realistic treatment phase, a proper washout window, and a conception attempt schedule that keeps you and a future pregnancy safe.

For women going through IVF — especially egg freezing — GLP-1 drugs used in the months before retrieval may meaningfully improve outcomes. The JCEM 2024 study mentioned earlier is important here: it specifically looked at pre-IVF semaglutide use in women with BMI over 30, and found both better egg quality (maturation rate) and better live birth rates. This is not a subtle effect. These are the outcomes that actually matter when you're spending tens of thousands of dollars on IVF.

The reason it works pre-retrieval but not during the cycle itself is timing. You want the metabolic benefits — better insulin sensitivity, lower androgens, improved follicular environment — to be in place when your follicles are developing, which is the 90 days or so before retrieval. Then you stop the drug well before the actual retrieval and transfer, with a proper washout window for embryo transfer. 🔬

There's also an exciting new development in IVF ovulation triggering: kisspeptin-54 received FDA approval in 2024 as an IVF trigger based on a Lancet trial of 237 women. Traditional IVF uses hCG to trigger final egg maturation, which carries a risk of ovarian hyperstimulation syndrome (OHSS) — a sometimes serious complication. Kisspeptin-54 triggers via a completely different pathway and showed no OHSS in the trial. This is particularly relevant for PCOS patients, who have the highest OHSS risk. Talk to your RE about whether this is an option at their clinic.

If you're planning an IVF cycle, a timeline that includes 3-4 months of GLP-1 treatment, a 2-3 month washout, and then retrieval is something worth discussing with your reproductive endocrinologist specifically. The research supports it for the right patient profile.

Not everyone going through this is planning IVF. A lot of women with PCOS are trying to conceive naturally and struggling with irregular or absent cycles that make timing nearly impossible. If you can't predict when you're ovulating — or if you're not ovulating at all — natural conception is a lottery you can't win.

GLP-1 drugs address the root cause of anovulation in PCOS for many women. The mechanism runs through insulin and androgens: high insulin drives the ovaries to produce excess testosterone, which suppresses the LH surge needed for ovulation. Restore insulin sensitivity and you lower testosterone. Lower testosterone and the LH surge can happen. Resume ovulation and you now have a cycle to work with. For 50-65% of anovulatory PCOS women, this is a pathway back to natural ovulation without injectables or IUI. 💪

The practical approach for natural TTC: use GLP-1 drugs to restore cycle regularity, track your cycles carefully (basal body temperature, LH strips, or an app like Selene that monitors your hormone patterns), confirm you're ovulating, then implement the washout protocol and start trying. The drug has done its job — setting up the hormonal environment — and now you stop it and let your restored physiology do the rest.

One more thing worth knowing: GLP-1 drugs also improve endometrial thickness and receptivity in some women. A well-prepared uterine lining is a prerequisite for implantation whether you're doing IVF or trying naturally. The drug addresses both sides of the fertility equation — egg quality and endometrial readiness — which is why the research on pre-conception GLP-1 use is so promising.